You are here
Veriskin, Inc.
http://www.veriskin.com
UEI: M9MBEBYMQ1N3
# of Employees: 3
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Pivotal Clinical Study of the TruScore Device for Non-Invasive Skin Cancer Diagnostics
Amount: $1,499,425.00Skin cancer is the most common form of cancer in the US with 5+ million diagnoses, over 27,000 lives lost each year and the annual treatment costs of over $8 billion. The early diagnosis of skin cance ...
SBIRPhase II2022Department of Health and Human Services National Institutes of Health -
Clinical performance of hemodynamics-based non-invasive device for skin cancer testing
Amount: $1,998,435.00Skin cancer is the most common form of cancer in the US, accounting for just under half of all diagnosed cancers (5+ million diagnoses), 27,000+ deaths each year and the annual treatment costs of over ...
SBIRPhase II2020Department of Health and Human Services National Institutes of Health -
Hemodynamic Noninvasive Skin Cancer Diagnostics
Amount: $1,876,174.00DESCRIPTIONprovided by applicantSkin cancer is the most common form of cancer in the USeach year accounting for just under half of all diagnosed cancersmillion diagnosesanddeaths with annual treatment ...
SBIRPhase II2016Department of Health and Human Services National Institutes of Health